SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-010712
Filing Date
2023-04-04
Accepted
2023-04-04 08:00:44
Documents
17
Period of Report
2023-03-30
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54984
2 ex10-1.htm EX-10.1 116169
3 ex99-1.htm EX-99.1 31510
4 ex10-1_001.jpg GRAPHIC 11425
5 ex10-1_002.jpg GRAPHIC 45916
6 ex99-1_001.jpg GRAPHIC 5888
  Complete submission text file 0001493152-23-010712.txt   500623

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE vbiv-20230330.xsd EX-101.SCH 3236
8 XBRL LABEL FILE vbiv-20230330_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE vbiv-20230330_pre.xml EX-101.PRE 22365
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3478
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 23795128
SIC: 2834 Pharmaceutical Preparations